Grant Count
4
Highest Funding Involved
$1,800,000.00
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
No related researchers have been discovered for organisation St Vincent'S Hospital.
Start Date: 01-2006
End Date: 07-2010
Amount: $455,115.00
Summary: Prediction of epilepsy seizure onset using nonlinear analysis of EEG recordings. This project will develop the theory and algorithms for reliable and robust prediction of the onset of epileptic seizures and the characterisation of epileptic seizures based on EEG data. Our interdisciplinary team consists of neuroscientists and systems engineers supported with clinicians and software developers. The team will develop the theory and design, implement and evaluate decision support software that is a .... Prediction of epilepsy seizure onset using nonlinear analysis of EEG recordings. This project will develop the theory and algorithms for reliable and robust prediction of the onset of epileptic seizures and the characterisation of epileptic seizures based on EEG data. Our interdisciplinary team consists of neuroscientists and systems engineers supported with clinicians and software developers. The team will develop the theory and design, implement and evaluate decision support software that is able to interpret eeg data and present epilepsy relevant information to clinicians and patients. Our methods are based on statistical signal processing, nonlinear dynamics (bifurcation and time-series methods) and systems engineering (system identification, adaptive methods). Read more Read less
Funder: Australian Research Council
View Funded ActivityStart Date: 07-2007
End Date: 01-2011
Amount: $259,067.00
Summary: Development of the PD GeneChip: a research and diagnostic tool for Parkinson's disease. The PD GeneChip will provide both social and economic benefits to Australia. It will be a key research platform for Australian scientists, and will facilitate collaboration both within Australia and overseas. It will assist with health care management of PD (Parkinson's disease) patients by providing a cost-effective diagnostic tool and the possibility of predicting the clinical course of disease. This inform .... Development of the PD GeneChip: a research and diagnostic tool for Parkinson's disease. The PD GeneChip will provide both social and economic benefits to Australia. It will be a key research platform for Australian scientists, and will facilitate collaboration both within Australia and overseas. It will assist with health care management of PD (Parkinson's disease) patients by providing a cost-effective diagnostic tool and the possibility of predicting the clinical course of disease. This information will provide the basis for tailoring treatment to a patients needs. It is anticipated that marketing of the PD GeneChip within Australia and overseas may produce revenue of at least $40 million annually. Read more Read less
Funder: Australian Research Council
View Funded ActivityStart Date: 04-2015
End Date: 06-2019
Amount: $1,800,000.00
Summary: ARC Training Centre in Biodevices. ARC Training Centre in Biodevices. The Training Centre aims to assist Australian biodevice and diagnostics companies to develop the next generation of innovative and profitable products that address important healthcare needs in our communities. This will be achieved by addressing industry-specific challenges relating to the multidisciplinary nature of design and development in the biodevices and diagnostics sector; technology uptake and transfer to manufacturi .... ARC Training Centre in Biodevices. ARC Training Centre in Biodevices. The Training Centre aims to assist Australian biodevice and diagnostics companies to develop the next generation of innovative and profitable products that address important healthcare needs in our communities. This will be achieved by addressing industry-specific challenges relating to the multidisciplinary nature of design and development in the biodevices and diagnostics sector; technology uptake and transfer to manufacturing; the composition, maturity and size of local firms in the sector; and the development of high-level entrepreneurial skills for innovative industry researchers. The Training Centre will remove barriers to collaboration between universities and industry by delivering exceptional return on research investment. Read more Read less
Funder: Australian Research Council
View Funded ActivityStart Date: 06-2009
End Date: 06-2012
Amount: $514,076.00
Summary: Structural and pharmaceutical studies on a novel human protein, MIC-1. Cancer and obesity are two of the main health problems facing Australia, as reflected by the National Research Priority: Promoting and Maintaining Good Health. This project will develop new diagnostic tools for early cancer detection and prognosis using the protein, MIC-1. MIC-1 is responsible for cachexia, a wasting disorder responsible for 25% of cancer deaths, which has no effective therapy. MIC-1 and antibodies neutrali .... Structural and pharmaceutical studies on a novel human protein, MIC-1. Cancer and obesity are two of the main health problems facing Australia, as reflected by the National Research Priority: Promoting and Maintaining Good Health. This project will develop new diagnostic tools for early cancer detection and prognosis using the protein, MIC-1. MIC-1 is responsible for cachexia, a wasting disorder responsible for 25% of cancer deaths, which has no effective therapy. MIC-1 and antibodies neutralising MIC-1 may provide therapeutic agents to control cancer cachexia and severe obesity. The project will optimise these molecules for therapeutic uses. These diagnostic and therapeutic tools will form the basis of a spin-off company for commercialisation. Read more Read less
Funder: Australian Research Council
View Funded Activity